A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription

Nature Structural and Molecular Biology

Volumn 14, Issue 7, 2007, Pages 653-661

  Wei, Yufeng ^a   Liu, Shaohua ^a   Lausen, Jörn ^a   Woodrell, Christopher ^a   Cho, Seongeun ^a   Biris, Nikolaos ^a   Kobayashi, Naohiro ^b   Wei, Yu ^a   Yokoyama, Shigeyuki ^b,c   Werner, Milton H ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b RIKEN YOKOHAMA INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR RECEPTOR COREPRESSOR; RNA POLYMERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; E BOX ELEMENT; ESCHERICHIA COLI; GENE FUSION; LEUKEMIA; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; YEAST;

ANIMALS; DNA-BINDING PROTEINS; DOWN-REGULATION; E-BOX ELEMENTS; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTOR TFIID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES; UP-REGULATION;

DROSOPHILA MELANOGASTER; ESCHERICHIA COLI;

EID: 34447114547     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb1258     Document Type: Article

References (53)

1. Davis, J.N., McGhee, L. & Meyers, S. The ETO (MTG8) gene family. Gene 303, 1-10 (2003).
2. Miyoshi, H. et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88, 10431-10434 (1991).
3. Miyoshi, H. et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 12, 2715-2721 (1993).
4. Erickson, P. et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80, 1825-1831 (1992).
5. Gamou, T. et al. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood 91, 4028-4037 (1998).
6. Look, A.T. Oncogenic transcription factors in the human acute leukemias. Science 278, 1059-1064 (1997).
7. Gelmetti, V. et al. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol. Cell. Biol. 18, 7185-7191 (1998).
8. Lutterbach, B. et al. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol. Cell. Biol. 18, 7176-7184 (1998).
9. Wang, J., Hoshino, T., Redner, R.L., Kajigaya, S. & Liu, J.M. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc. Natl. Acad. Sci. USA 95, 10860-10865 (1998).
10. Lausen, J., Cho, S., Liu, S. & Werner, M.H. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO. J. Biol. Chem. 279, 49281-49288 (2004).
11. Minucci, S. et al. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol. Cell 5, 811-820 (2000).
12. Zhang, J. et al. Oligomerization of ETO is obligatory for corepressor interaction. Mol. Cell. Biol. 21, 156-163 (2001).
13. Liu, Y. et al. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell 9, 249-260 (2006).
14. Hiebert, S.W., Lutterbach, B. & Amann, J. Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins. Curr. Opin. Hematol. 8, 197-200 (2001).
15. Lausen, J., Liu, S., Fliegauf, M., Lubbert, M. & Werner, M.H. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO. Oncogene 25, 1349-1357 (2006).
16. Shimada, H. et al. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. Blood 96, 655-663 (2000).
17. Andersson, A. et al. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. Leukemia 19, 1042-1050 (2005).
18. Dunne, J. et al. siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts. Oncogene 25, 6067-6078 (2006).
19. Yan, M. et al. Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development. Proc. Natl. Acad. Sci. USA 101, 17186-17191 (2004).
20. Rhoades, K.L. et al. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood 96, 2108-2115 (2000).
21. Yuan, Y. et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc. Natl. Acad. Sci. USA 98, 10398-10403 (2001).
22. Higuchi, M. et al. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1, 63-74 (2002).
23. de Guzman, C.G. et al. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. Mol. Cell. Biol. 22, 5506-5517 (2002).
24. Amann, J.M. et al. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol. Cell. Biol. 21, 6470-6483 (2001).
25. Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T. & Roeder, R.G. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 305, 1286-1289 (2004).
26. Malhotra, A., Severinova, E. & Darst, S.A. Crystal structure of a sigma 70 subunit fragment from E. coli RNA polymerase. Cell 87, 127-136 (1996).
27. Armache, K.J., Mitterweger, S., Meinhart, A. & Cramer, P. Structures of complete RNA polymerase II and its subcomplex, Rpb4/7. J. Biol. Chem. 280, 7131-7134 (2005).
28. Cornilescu, G., Delaglio, F. & Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289-302 (1999).
29. Güntert, P. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278, 353-378 (2004).
30. Schwieters, C.D., Kuszewski, J.J., Tjandra, N. & Clore, G.M. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160, 65-73 (2003).
31. Clore, G.M. & Garrett, D.S. R-factor, Free R and complete cross-validation for dipolar coupling refinement of NMR structures. J. Am. Chem. Soc. 121, 9008-9012 (1999).
32. Spronk, C.A., Linge, J.P., Hilbers, C.W. & Vuister, G.W. Improving the quality of protein structures derived by NMR spectroscopy. J. Biomol. NMR 22, 281-289 (2002).
33. Plevin, M.J., Zhang, J., Guo, C., Roeder, R.G. & Ikura, M. The acute myeloid leukemia fusion protein AML1-ETO targets E proteins via a paired amphipathic helix-like TBP-associated factor homology domain. Proc. Natl. Acad. Sci. USA 103, 10242-10247 (2006).
34. Nomura, M., Uda-Tochio, H., Murai, K., Mori, N. & Nishimura, Y. The neural repressor NRSF/REST binds the PAH1 domain of the Sin3 corepressor by using its distinct short hydrophobic helix. J. Mol. Biol. 354, 903-915 (2005).
35. Swanson, K.A. et al. HBP1 and Mad1 repressors bind the Sin3 co-repressor PAH2 domain with opposite helical orientations. Nat. Struct. Mol. Biol. 11, 738-746 (2004).
36. Spronk, C.A. et al. The Mad1-Sin3B interaction involves a novel helical fold. Nat. Struct. Biol. 7, 1100-1104 (2000).
37. Kolodziej, P.A., Woychik, N., Liao, S.M. & Young, R.A. RNA polymerase II subunit composition, stoichiometry, and phosphorylation. Mol. Cell. Biol. 10, 1915-1920 (1990).
38. Choder, M. Rpb4 and Rpb7: subunits of RNA polymerase II and beyond. Trends Biochem. Sci. 29, 674-681 (2004).
39. Petermann, R. et al. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene 17, 603-610 (1998).
40. Beier, D., Spohn, G., Rappuoli, R. & Scarlato, V. Functional analysis of the H. pylori principal sigma subunit of RNA polymerase reveals that the spacer region is important for efficient transcription. Mol. Microbiol. 30, 121-134 (1998).
41. Murre, C. Helix-loop-helix proteins and lymphocyte development. Nat. Immunol. 6, 1079-1086 (2005).
42. Massari, M.E., Jennings, P.A. & Murre, C. The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells. Mol. Cell. Biol. 16, 121-129 (1996).
43. Dominguez, C., Boelens, R. & Bonvin, A.M.J.J. HADDOCK: a protein-protein docking approach based on biochemical and/or biophysical information. J. Am. Chem. Soc. 125, 1731-1737 (2003).
44. Zor, T., DeGuzman, R.N., Dyson, H.J. & Wright, P.E. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. J. Mol. Biol. 337, 521-534 (2004).
45. Perissi, V. & Rosenfeld, M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 6, 542-554 (2005).
46. Pabst, T. et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat. Med. 7, 444-445 (2001).
47. Tighe, J.E. & Calabi, F. Alternative, out-of-frame runt/MTG8 transcripts are encoded by the derivative (8) chromosome in the t(8;21) of acute myeloid leukemia M2. Blood 84, 2115-2121 (1994).
48. van de Locht, L.T., Smetsers, T.F., Wittebol, S., Raymakers, R.A. & Mensink, E.J. Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia. Leukemia 8, 1780-1784 (1994).
49. Wolford, J.K. & Prochazka, M. Structure and expression of the human MTG8/ETO gene. Gene 212, 103-109 (1998).
50. McNeil, S. et al. The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor. Proc. Natl. Acad. Sci. USA 96, 14882-14887 (1999).
51. Meyers, S. & Hiebert, S.W. Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia. J. Cell. Biochem. Suppl. 35, 93-98 (2000).
52. Laskowski, R.A., Rullmann, J.A.C., MacArthur, M.W., Kaptein, R. & Thornton, J.M. AQUA and PROCHECK_NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477-486 (1996).
53. Hooft, R.W.W., Vriend, G., Sander, C. & Abola, E.E. Errors in protein structures. Nature 381, 272 (1996).